BlackRock’s Cryo-Cell International CCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding CCEL
SA
MPWT
BlackRock's CCEL Position: Q2 2026 in Review
BlackRock reduced its Cryo-Cell International (CCEL) stake by 52% in Q2 2026, selling an estimated $25.9K and leaving 6,696 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5351.
BlackRock first reported a position in CCEL in Q2 2022 and has held it in 17 quarters since. The position peaked at $101K in Q4 2024. 12 funds tracked by Wall St. Rank hold CCEL as of Q2 2026.
- BlackRock held 6,696 shares of Cryo-Cell International worth $21.4K as of Q2 2026.
- BlackRock sold 7,287 Cryo-Cell International shares in Q2 2026, an estimated $25.9K.
- Cryo-Cell International made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5351 holding.
- BlackRock first reported a position in Cryo-Cell International in Q2 2022 and has held it in 17 quarters since.
- BlackRock's Cryo-Cell International position peaked at $101K in Q4 2024.
- 12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.